Documents Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 SYNERGY

PowerPoint Presentation Ledipasvir-Sofosbuvir +/- 3rd DAA in HCV Genotype 1 NIAID SYNERGY: Genotype 1 Phase 2 Treatment Naïve (unfavorable baseline treatment characteristics)…

Documents Ledipasvir-sofosbuvir +/- 3 rd DAA in HCV Genotype 1 NIH SYNERGY

PowerPoint Presentation Ledipasvir-Sofosbuvir +/- 3rd DAA in HCV Genotype 1 NIH SYNERGY Phase 2 Treatment Naïve (unfavorable baseline treatment characteristics) Kohli…

Documents Ledipasvir-Sofosbuvir in GT-1 and HIV Coinfection ERADICATE Trial

PowerPoint Presentation Ledipasvir-Sofosbuvir in GT-1 and HIV Coinfection NIAID ERADICATE Trial Phase 2a Treatment Naïve and Treatment Experienced Osinusi A, et al. JAMA.…